FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

303811000001100: Angeze 10 tablets (Opus Pharmaceuticals) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
16335701000001116 Angeze 10 tablets (Opus Pharmaceuticals) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
41130901000001119 Angeze 10 tablets (Opus Pharmaceuticals Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Angeze 10 tablets (Opus Pharmaceuticals) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Angeze 10 tablets (Opus Pharmaceuticals) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Angeze 10 tablets (Opus Pharmaceuticals) Is a Product containing precisely isosorbide mononitrate 10 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Angeze 10 tablets (Opus Pharmaceuticals) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Angeze 10 tablets (Opus Pharmaceuticals) Has excipient Lactose false Inferred relationship Existential restriction modifier
Angeze 10 tablets (Opus Pharmaceuticals) Has active ingredient Osmotic diuretic false Inferred relationship Existential restriction modifier
Angeze 10 tablets (Opus Pharmaceuticals) Has active ingredient Isosorbide mononitrate false Inferred relationship Existential restriction modifier
Angeze 10 tablets (Opus Pharmaceuticals) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Angeze 10 tablets (Opus Pharmaceuticals) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Angeze 10 tablets (Opus Pharmaceuticals) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Angeze 10 tablets (Opus Pharmaceuticals) Is a Angeze true Inferred relationship Existential restriction modifier
Angeze 10 tablets (Opus Pharmaceuticals) Has specific active ingredient Isosorbide mononitrate true Inferred relationship Existential restriction modifier
Angeze 10 tablets (Opus Pharmaceuticals) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Angeze 10 tablets (Opus Pharmaceuticals) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Angeze 10 tablets (Opus Pharmaceuticals) 56 tablet 4 x 14 tablets Is pack of False Angeze 10 tablets (Opus Pharmaceuticals) Inferred relationship Existential restriction modifier
Angeze 10 tablets (Opus Pharmaceuticals) 56 tablet 4 x 14 tablets Has AMP True Angeze 10 tablets (Opus Pharmaceuticals) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start